By [ad_1]
Sheldon, who was one of AstraZeneca’s most senior employees, is set to start at GSK in September. The executive had access to confidential information in a whole host of sensitive areas including the firm’s cancer work, AstraZeneca said in a legal filing. He was paid more than £644,000 ($774,090) in shares in 2021 to sign the non-compete clause.
[ad_2]
Source link
What is your reaction?
Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0
